Toggle navigation
Home
Pulse
Channels
CME
Profile
Home
Pulse
Channels
CME
Profile
Shivangini Duggal's Talks
Shivangini Duggal
Texas Tech University Health Sciences Center, El Paso, TX
The Validity of mRECIST in Immunotherapy
July 7, 2025
Shivangini Duggal
Texas Tech University Health Sciences Center, El Paso, TX
Survival Outcomes Following CR
July 7, 2025
Share
Survival Outcomes Following CR
https://www.medspoke.co/channel_playlist?object_id=785&tap_id=9557
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Shivangini Duggal
Texas Tech University Health Sciences Center, El Paso, TX
Defining Response – RECIST vs. mRECIST
July 7, 2025
Why are you reporting this TALK?
